Healthcare Industry News: Bovie
News Release - July 12, 2006
Bovie Medical Corporation Announces the Filing of an FDA 510(K) Application for New GI Device: Anticipates over 30% Growth in Revenue for the Second QuarterMELVILLE, N.Y.--(HSMN NewsFeed)--July 12, 2006--Bovie Medical Corporation (the "Company") (Amex: BVX ), a manufacturer and marketer of electrosurgical products, today announced the filing with the Food and Drug Administration (FDA) of a 510(K) application for an electrosurgical product for the gastroenterological market. The GI device has been designed in conjunction with input from GI surgeons and nurses, offering many features including a touch screen interface, physician preference database, neutral electrode monitoring, and common sense messages.
Andrew Makrides, president of Bovie, added, "We are poised to enter a growing GI market where statistics indicate that the number of colonoscopies performed in the United States is increasing at a dramatic rate. The GI ICON(TM) demonstrates Bovie's strong commitment to design and develop technologies that improve patient care and the manner in which physicians deliver it."
In other news, the Company expects to report in August that the recently completed second quarter was the highest revenue quarter in Company history.
This document may contain some forward looking statements, particularly regarding operational prospects in 2006 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings.
Source: Bovie Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.